4//SEC Filing
Haas Jason 4
Accession 0000950170-24-129378
CIK 0001556263other
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 5:00 PM ET
Size
5.0 KB
Accession
0000950170-24-129378
Insider Transaction Report
Form 4
Haas Jason
Chief Financial Officer
Transactions
- Sale
Common Stock
2024-11-18$0.21/sh−137,803$28,980→ 0 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.19 to $0.2295, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Documents
Issuer
Syros Pharmaceuticals, Inc.
CIK 0001556263
Entity typeother
Related Parties
1- filerCIK 0001883821
Filing Metadata
- Form type
- 4
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 5:00 PM ET
- Size
- 5.0 KB